Hepatitis and Liver Diseases: Diagnosis, Treatment, and Prevention

Hepatitis and Liver Diseases

In our liver clinic, we offer a comprehensive hepatological assessment of both infectious and non-infectious liver conditions.

Not only infectious hepatitis such as hepatitis B and C, but also liver inflammation caused by overweight, alcohol consumption, or diabetes, as well as autoimmune liver diseases and storage disorders, can lead to fatty changes in the liver tissue (“fatty liver”), progressing to cirrhosis or liver cancer.

Abdominal ultrasound allows early detection of liver tissue changes, masses such as tumours, vascular alterations, or cirrhosis.

We advise you on options to achieve a cure or to prevent progression of the liver disease, wherever possible.

Medication Studies

Particularly for patients with liver diseases, we can offer access to novel medications not yet widely available through clinical studies, as a partner of Epimed. Please contact us if you are interested.

Hepatitis B

Hepatitis B is one of the most common infections worldwide. The virus can be transmitted via blood (e.g., at birth or through needlestick injuries) or sexually.

Population-wide screening from age 35, as part of routine health checks, has identified many previously undetected or asymptomatic hepatitis B infections, allowing for appropriate treatment and monitoring. This helps prevent long-term complications such as cirrhosis and liver cancer.

Not all chronic hepatitis B infections require medication. We provide guidance on monitoring and treatment in all life situations—including pregnancy or HBV/HIV co-infection.

A safe and effective vaccine against hepatitis B is available. We are happy to advise patients’ close contacts to help prevent transmission.

Hepatitis C

Worldwide, approximately 50 million people live with hepatitis C. The virus is mainly transmitted via blood and, less commonly, sexually. Infection often occurs without noticeable symptoms. Population-wide screening from age 35 has helped identify many previously undiagnosed chronic hepatitis C infections.

Modern hepatitis C treatments can achieve a cure and prevent long-term complications such as cirrhosis and liver cancer.

Patients with chronic hepatitis C receive close monitoring throughout the two- to three-month treatment period to ensure successful therapy. If necessary, we also collaborate with addiction medicine services.

Currently, no vaccine exists for hepatitis C.